TriLink Gets $100K NIGMS Grant to Develop PCR Technology | GenomeWeb
NEW YORK (GenomeWeb News) - TriLink Biotechnologies, a maker of customized nucleic acid products, said today it has received a $100,000 Phase I Small Business Innovation Research grant from the National Institutes of Health to study a novel approach to PCR activation.
 
The NIH's National Institute of General Medical Sciences awarded the grant.
 
The company said its so-called Hot Start PCR method uses chemically modified triphosphates that inhibit DNA polymerase activity until a thermal activation step.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.